4D Molecular Therapeutics, Inc. (FDMT)
10.83
+0.32
(+3.04%)
USD |
NASDAQ |
Dec 10, 16:00
10.82
-0.01
(-0.09%)
After-Hours: 20:00
4D Molecular Therapeutics Free Cash Flow: -185.05M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aura Biosciences, Inc. | -88.80M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -46.50M |
| Cash from Investing (Quarterly) | 17.78M |
| Cash from Financing (Quarterly) | 0.116M |
| Free Cash Flow Per Share (Quarterly) | -0.8268 |
| Free Cash Flow to Equity (Quarterly) | -45.59M |
| Free Cash Flow to Firm (Quarterly) | -46.41M |
| Free Cash Flow Yield | -32.00% |